常見的血液腫瘤主要包括各類白血病、多發性脊髓瘤以及惡性淋巴瘤。急性白血病占常見惡性腫瘤的第八位，淋巴瘤也是在前十位，并且發病率逐年升高，多發性骨髓瘤的整個發病率在血液惡性腫瘤里面占10%。 以下產品可用于多種常見血液腫瘤研究，急性淋巴細胞白血病（Acute Lymphoblastic Leukemia (ALL)是一種起源于淋巴細胞的B系或T系細胞在骨髓內異常增生的惡性腫瘤疾病。異常增生的原始細胞可在骨髓聚集并抑制正常造血功能，同時也可侵及骨髓外的組織，如腦膜、淋巴結、性腺、肝等。急性髓細胞白血病(acute myelocytic leukemia，AML)包括所有非淋巴細胞來源的急性白血病，是多能干細胞或已輕度分化的前體細胞核型發生突變所形成的一類疾病是造血系統的克隆性惡性疾病。淋巴瘤（Lymphoma）是起源于淋巴造血系統的惡性腫瘤，主要表現為無痛性淋巴結腫大，肝脾腫大。 相關產品列表： |
| 急性淋巴細胞白血病相關抗體 Antibody Catalog No. Host Clone Reactivity Tested Application/s CD3 NBP2-25186 Ms OKT3 Hu FLOW CD19 NBP2-25196 Ms CD19 Hu FLOW, IHC IL2RA/CD25 NBP2-27425 Rt PC61 Ms FLOW CD44 NBP1-47386 Ms 8E2F3 Hu, Ms, Ca, Rb, Eq WB, ELISA, FLOW, ICC/IF, IHC, IHC-P Notch-1 NB100-78486 Ms mN1A Hu, Ms WB, FLOW, ICC/IF, IHC, IHC-P, IP |
| 急性髓細胞樣白血病相關抗體 Antibody Catalog No. Host Clone Reactivity Tested Application/s c-Kit NB100-77477 Rt 2B8 Hu, Ms FLOW, IHC, IHC-Fr, IP ETV6/Tel NBP1-80695 Rb poly Hu, Rt WB, ICC/IF, IHC, IHC-P Flt3/CD135 NBP1-43352 Rt A2F10 Ms FLOW, Func, IP Nucleophosmin NB110-61646 Rb poly Hu, Ms WB, FLOW, ICC/IF, IHC, IHC-P, IP RUNX1 NB100-2044 Rb poly Hu, Ms WB |
| 淋巴瘤相關抗體 Antibody Catalog No. Host Clone Reactivity Tested Application/s Bcl2 NB100-56098 Rb poly Hu, Bv, Ca, Fe WB, IHC, IHC-P, IP CD5 NBP2-02690 Ms 7A7 Hu WB, FLOW, ICC/IF, IHC, IHC-P CD10 NBP1-47356 Ms 2A1H5E1 Hu WB, ELISA, ICC/IF, IHC, IHC-P CD15 NBP1-28441 Ms 28 Hu FLOW, IHC, IHC-Fr, IP CD30 NBP2-29425 Ms CD30/412 Hu ELISA, FLOW, ICC/IF, IHC-Fr, IHC-P |
| 多發性骨髓瘤相關抗體 Antibody Catalog No. Host Clone Reactivity Tested Application/s beta 2 microglobulin NB500-317 Ms B2M-01 Hu WB, ELISA, FLOW, IHC, IHC-P, IP, RIA CD38 NBP2-25250 Ms 1G7F4 Hu, Ms WB, IHC, IHC-P CD56 + NCAM-1 NBP2-15184 Ms 123C3 Hu, Rt, Ze WB, ELISA, FLOW, ICC/IF, IHC-Fr, IHC-P, IP IL-6 NB600-1131 Rb poly Hu, Ms, Rt WB, ELISA, ICC/IF, IHC, IHC-P, IP Syndecan 1 NBP1-54523 Ms MI15 Hu FLOW, ICC/IF, IHC, IHC-P |
|
| CD3 NBP02-25186 CD10 NBP1-47356 IL-6 NB600-1131 |
